Harold Burstein
MD, PhD
Institute Physician, Breast Oncology
👥Biography 个人简介
Harold Burstein has played a central role in the MONALEESA program establishing ribociclib overall survival benefit in HR-positive advanced breast cancer. He is a leading voice on ASCO guidelines for HR-positive disease. His work shapes shared decision-making on CDK4/6 inhibitor selection.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Harold Burstein 的研究动态
Follow Harold Burstein's research updates
留下邮箱，当我们发布与 Harold Burstein（Dana-Farber Cancer Institute / Harvard Medical School）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment